Submit Article Author Guidelines
    Vol 14 Issue 2

    RETRACTED: Synthesis and Biological Evaluation of Novel 5,5-Diphenylimidazolidine Derivatives with Anticonvulsant Activity

    Updated:1 Min Read
    Rohit Jaysing Bhor, Wayse Siddheshwar Sunil, Rahul Bapusaheb Shirole, Karan Suresh Kadam, Santosh Dighe and Mahesh Hari Kolhe
    Author informationPDFCitations

    Department of Pharmaceutical Chemistry, Pravara Rural College of Pharmacy, Pravaranagar, Rahata, Ahmednagar, Maharashtra, INDIA

    Corresponding author.

    Correspondence: Dr. Rohit Jaysing Bhor Department of Pharmaceutical Chemistry, Pravara Rural College of Pharmacy, Pravaranagar, Rahata, Ahmednagar, Maharashtra, INDIA. Email: rohit.bhor69@gmail.com ORCID ID: 0000-0002-7979-3765

    Author Notes

    Received August 26, 2023; Revised October 01, 2023; Accepted November 03, 2023.
    Download PDF Format
    Cite This Article
    Read In Lens
    Metrics Citations & Stats
    1.Bhor RJ, Sunil WS, Shirole RB, Kadam KS, Dighe S, Kolhe MH. Synthesis and Biological Evaluation of Novel 5,5-Diphenylimidazolidine Derivatives with Anticonvulsant Activity. International Journal of Pharmaceutical Investigation [Internet]. 2024 Apr 2;14(2):350–8. Available from: http://dx.doi.org/10.5530/ijpi.14.2.43
    Published in: International Journal of Pharmaceutical Investigation, 2024; 14(2): 350-358.Published online: 02 April 2024DOI: 10.5530/ijpi.14.2.43

    ABSTRACT

    The article has been retracted based on the author’s request.
    ←Previous ArticleSynergestic Cytotoxicity of Doxorubicin in Combination with Epigallocatechin 3-gallate in Non-Small Cell Lung Cancer by Inhibiting Protein Vimentin
    Next Article→Evaluation of Hypotensive and Vasodilatory Effects of Murraya koenigii Leaves Extract in L-NAME Induced Hypertensive Rats in Relation with Muscarinic Receptors

    Related Posts

    ×

    Cite This Article

    1.Bhor RJ, Sunil WS, Shirole RB, Kadam KS, Dighe S, Kolhe MH. Synthesis and Biological Evaluation of Novel 5,5-Diphenylimidazolidine Derivatives with Anticonvulsant Activity. International Journal of Pharmaceutical Investigation [Internet]. 2024 Apr 2;14(2):350–8. Available from: http://dx.doi.org/10.5530/ijpi.14.2.43